93 related articles for article (PubMed ID: 14680204)
1. Tranexamic acid in paediatric cardiac surgery.
Chauhan S; Bisoi A; Modi R; Gharde P; Rajesh MR
Indian J Med Res; 2003 Aug; 118():86-9. PubMed ID: 14680204
[TBL] [Abstract][Full Text] [Related]
2. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination?
Bulutcu FS; Ozbek U; Polat B; Yalçin Y; Karaci AR; Bayindir O
Paediatr Anaesth; 2005 Jan; 15(1):41-6. PubMed ID: 15649162
[TBL] [Abstract][Full Text] [Related]
3. Tranexamic acid as a means of reducing the need for blood and blood component therapy in children undergoing open heart surgery for congenital cyanotic heart disease.
Vacharaksa K; Prakanrattana U; Suksompong S; Chumpathong S
J Med Assoc Thai; 2002 Sep; 85 Suppl 3():S904-9. PubMed ID: 12452228
[TBL] [Abstract][Full Text] [Related]
4. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic tranexamic acid in elective, primary coronary artery bypass surgery using cardiopulmonary bypass.
Andreasen JJ; Nielsen C
Eur J Cardiothorac Surg; 2004 Aug; 26(2):311-7. PubMed ID: 15296889
[TBL] [Abstract][Full Text] [Related]
6. Tranexamic acid reduces blood loss and transfusion in reoperative cardiac surgery.
Dryden PJ; O'Connor JP; Jamieson WR; Reid I; Ansley D; Sadeghi H; Burr LH; Munro AI; Merrick PM
Can J Anaesth; 1997 Sep; 44(9):934-41. PubMed ID: 9305556
[TBL] [Abstract][Full Text] [Related]
7. Tranexamic acid: an alternative to aprotinin as antifibrinolytic therapy in pediatric congenital heart surgery.
Schindler E; Photiadis J; Sinzobahamvya N; Döres A; Asfour B; Hraska V
Eur J Cardiothorac Surg; 2011 Apr; 39(4):495-9. PubMed ID: 20832330
[TBL] [Abstract][Full Text] [Related]
8. [Effect of tranexamic acid on postoperative bleeding in pediatric heart surgery].
Varela Crespo CA; Sanabria Carretero P; Palomero Rodríguez MA; Tormo las de Heras C; Rodríguez Pérez E; Goldman Tarlousky L
Rev Esp Anestesiol Reanim; 2007 Mar; 54(3):155-61. PubMed ID: 17436653
[TBL] [Abstract][Full Text] [Related]
9. [Antifibrinolytic agents and repeat open-heart surgery: a comparison of tranexamic acid and low dose aprotinin].
Ait Houssa M; Selkane C; Amahzoune B; El Bekkali Y; Wahid FA; Moutaki Allah Y; Boulahya A; Ibat D; Drissi M; Azendour H; Elkirat A
Ann Cardiol Angeiol (Paris); 2007 Dec; 56(6):308-12. PubMed ID: 17976511
[TBL] [Abstract][Full Text] [Related]
10. Comparison of epsilon aminocaproic acid and tranexamic acid in pediatric cardiac surgery.
Chauhan S; Das SN; Bisoi A; Kale S; Kiran U
J Cardiothorac Vasc Anesth; 2004 Apr; 18(2):141-3. PubMed ID: 15073700
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
Elwatidy S; Jamjoom Z; Elgamal E; Zakaria A; Turkistani A; El-Dawlatly A
Spine (Phila Pa 1976); 2008 Nov; 33(24):2577-80. PubMed ID: 19011538
[TBL] [Abstract][Full Text] [Related]
12. Fibrinolytic inhibitors in off-pump coronary surgery: a prospective, randomized, double-blind TAP study (tranexamic acid, aprotinin, placebo).
Vanek T; Jares M; Fajt R; Straka Z; Jirasek K; Kolesar M; Brucek P; Maly M
Eur J Cardiothorac Surg; 2005 Oct; 28(4):563-8. PubMed ID: 16125959
[TBL] [Abstract][Full Text] [Related]
13. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial.
Later AF; Maas JJ; Engbers FH; Versteegh MI; Bruggemans EF; Dion RA; Klautz RJ
Eur J Cardiothorac Surg; 2009 Aug; 36(2):322-9. PubMed ID: 19250838
[TBL] [Abstract][Full Text] [Related]
14. Effect of topical tranexamic acid in open heart surgery.
Abul-Azm A; Abdullah KM
Eur J Anaesthesiol; 2006 May; 23(5):380-4. PubMed ID: 16438759
[TBL] [Abstract][Full Text] [Related]
15. Topical and low-dose intravenous tranexamic acid in cyanotic cardiac surgery.
Patel J; Prajapati M; Patel H; Gandhi H; Deodhar S; Pandya H
Asian Cardiovasc Thorac Ann; 2017 Feb; 25(2):118-122. PubMed ID: 28068786
[TBL] [Abstract][Full Text] [Related]
16. Tranexamic acid versus ɛ-aminocaproic acid: efficacy and safety in paediatric cardiac surgery.
Martin K; Breuer T; Gertler R; Hapfelmeier A; Schreiber C; Lange R; Hess J; Wiesner G
Eur J Cardiothorac Surg; 2011 Jun; 39(6):892-7. PubMed ID: 21115357
[TBL] [Abstract][Full Text] [Related]
17. Beneficial effect of both tranexamic acid and aprotinin on blood loss reduction in reoperative valve replacement surgery.
Jamieson WR; Dryden PJ; O'Connor JP; Sadeghi H; Ansley DM; Merrick PM
Circulation; 1997 Nov; 96(9 Suppl):II-96-100; discussion II-100-1. PubMed ID: 9386082
[TBL] [Abstract][Full Text] [Related]
18. Tranexamic acid therapy in pediatric cardiac surgery: a single-center study.
Giordano R; Palma G; Poli V; Palumbo S; Russolillo V; Cioffi S; Mucerino M; Mannacio VA; Vosa C
Ann Thorac Surg; 2012 Oct; 94(4):1302-6. PubMed ID: 22819471
[TBL] [Abstract][Full Text] [Related]
19. [Haemorrhage and morbidity associated with the use of tranexamic acid in cardiac surgery: a retrospective, multicentre cohort study].
Peña JJ; Mateo E; Martín E; Llagunes J; Carmona P; Blasco L;
Rev Esp Anestesiol Reanim; 2013 Mar; 60(3):142-8. PubMed ID: 22795924
[TBL] [Abstract][Full Text] [Related]
20. The blood sparing effect and the safety of aprotinin compared to tranexamic acid in paediatric cardiac surgery.
Breuer T; Martin K; Wilhelm M; Wiesner G; Schreiber C; Hess J; Lange R; Tassani P
Eur J Cardiothorac Surg; 2009 Jan; 35(1):167-71; author reply 171. PubMed ID: 19027313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
